Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial.

Lindsay Yoder¹, Elliot B Tapper², Richard Kalman³

¹Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, Indiana, USA.

Hepatology Communications

|June 19, 2026

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.

Expert review of pharmacoeconomics & outcomes research·2026

Same author

Caregiver Involvement and Burden and Patient Quality of Life in Patients with Decompensated Cirrhosis.

The American journal of gastroenterology·2026

Same author

Pain, uncertainty, and lack of clinical support drive emergency department utilization in cirrhosis: A qualitative study.

Hepatology communications·2026

Same author

Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management.

Nature reviews. Gastroenterology & hepatology·2026

Same author

The Cirrhosis Medical Home: A Pilot Randomized Trial of a Collaborative Care Model for Patients With Decompensated Cirrhosis.

Clinical and translational gastroenterology·2026

Same author

Mental health and health-related quality of life in a contemporary cohort of liver transplant survivors: the 'PROMIS' of liver transplant.

Psychology, health & medicine·2026

Same journal

Financial burden among liver transplant candidates is associated with financial distress and work impairment: A U.S. multicenter study.

Hepatology communications·2026

Same journal

Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm.

Hepatology communications·2026

Same journal

Hepatology e-consult responses generated by artificial intelligence demonstrate accuracy but require human oversight.

Hepatology communications·2026

Same journal

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.

Hepatology communications·2026

Same journal

The PERK-GADD45A axis is a key driver of hepatic stellate cell activation.

Hepatology communications·2026

Same journal

Progression of MASH to cirrhosis, decompensation, and mortality, and the utility of NITs for detection and risk stratification.

Hepatology communications·2026

See all related articles

This summary is machine-generated.

A new Transitional Liver Clinic (TLC) model using advanced practice providers (APPs) aims to reduce hospital readmissions for advanced liver disease patients. This study assesses its effectiveness in improving patient outcomes and satisfaction.

Area of Science:

Hepatology
Transitional Care
Clinical Trials

Background:

Advanced liver disease patients face high hospital readmission rates post-discharge.
Transitional care models show promise in other chronic conditions but need validation in liver disease.
The Transitional Liver Clinic (TLC) is a tailored model to address these gaps.

Purpose of the Study:

To evaluate the effectiveness of the TLC intervention in reducing 30-day hospital readmissions for advanced liver disease patients.
To assess the TLC's impact on quality of life and patient satisfaction.
To determine if a structured, APP-led model can improve post-discharge care in hepatology.

Main Methods:

A 45-month, stepped-wedge cluster randomized trial involving up to 1000 patients across 4 academic medical centers.

Keywords:

hospital readmission liver diseases patient satisfaction quality of life transitional care

Related Experiment Videos

Last Updated: Jun 20, 2026

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

Intervention: Post-discharge phone call within 2 business days and a hepatology APP visit within 14 days.

Primary outcome: 30-day hospital readmission; Secondary outcomes: 90-day readmission, ER visits, mortality, quality of life, patient satisfaction.

Main Results:

This section is to be filled once the trial concludes and results are available.

Conclusions:

This multicenter randomized trial will determine the efficacy of a structured, APP-led transitional care model for advanced liver disease.
If successful, the TLC model offers a potentially scalable solution for post-discharge care in hepatology.